Frank Guarnieri is currently working as a Chief Technology Officer at CO2Change. He is also a Chief Scientific Officer at Sustained Therapeutics. He is also an Affiliate Professor at the Center for Drug Discovery at Northeastern University. He obtained his Ph.D. from New York University. He specialized in chemistry.